Guideline Guideline for the Diagnosis and Treatment of Diabetes Mellitus in Patients With Transfusion-Dependent Thalassemia



Khamseh ME¹ ; Malek M² ; Hashemimadani N¹ ; Ghassemi F³ ; Rahimian N¹ ; Ziaee A³ ; Foroughigilvaee MR³ ; Faranoush P³ ; Sadighnia N³ ; Elahinia A³ ; Saeedi V¹ ; Rezvany MR³ ; Faranoush M³ Show Affiliations
Source: Iranian Journal of Blood and Cancer Published:2023

Abstract

Thalassemia major hemoglobinopathy requires regular blood transfusions, often leading to iron overload due to repeated transfusions and increased intestinal iron absorption. The association between thalassemia major and metabolic complications, including diabetes and metabolic syndrome, has been recognized due to iron overload, insulin secretion impairment, insulin resistance, hepatic dysfunction, and other endocrine complications. These hormonal imbalances can also influence glucose metabolism and contribute to the development of metabolic syndrome. It's essential for individuals with thalassemia major to undergo regular monitoring of their glucose metabolism, including periodic assessments of fasting blood glucose, oral glucose tolerance tests, and measurement of Fructosamine. Early detection and management of diabetes and metabolic syndrome in thalassemia major patients are crucial to minimize complications and optimize overall health. Medical management may involve a combination of regular blood transfusions, iron chelation therapy to reduce iron overload, lifestyle modifications such as a healthy diet and physical activity, and, if needed, pharmacological interventions for glycemic control. Close collaboration between hematologists and endocrinologists is often necessary to provide comprehensive care for individuals with thalassemia major and metabolic complications. © 2023, Iranian Pediatric Hematology and Oncology Society. All rights reserved.